NOVAREX Co.,Ltd. (KOSDAQ:194700)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,600
-210 (-1.42%)
At close: Apr 28, 2026
48.52%
Market Cap 258.45B
Revenue (ttm) 404.26B
Net Income (ttm) 35.42B
Shares Out 17.70M
EPS (ttm) 2,000.00
PE Ratio 7.30
Forward PE n/a
Dividend 400.00 (2.70%)
Ex-Dividend Date Dec 29, 2025
Volume 42,798
Average Volume 43,966
Open 14,950
Previous Close 14,810
Day's Range 14,420 - 14,950
52-Week Range 9,700 - 22,100
Beta 0.22
RSI 59.46
Earnings Date Apr 3, 2026

About NOVAREX

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 464
Stock Exchange KOSDAQ
Ticker Symbol 194700
Full Company Profile

Financial Performance

In 2025, NOVAREX's revenue was 404.26 billion, an increase of 35.78% compared to the previous year's 297.73 billion. Earnings were 35.42 billion, an increase of 53.87%.

Financial Statements

News

There is no news available yet.